title: Building and Strengthening Infection Control Strategies to Prevent Tuberculosis - Nigeria, 2015.
abstract: Tuberculosis (TB) is the leading cause of infectious disease mortality worldwide, accounting for more than 1.5 million deaths in 2014, and is the leading cause of death among persons living with human immunodeficiency virus (HIV) infection (1). Nigeria has the fourth highest annual number of TB cases among countries, with an estimated incidence of 322 per 100,000 population (1), and the second highest prevalence of HIV infection, with 3.4 million infected persons (2). In 2014, 100,000 incident TB cases and 78,000 TB deaths occurred among persons living with HIV infection in Nigeria (1). Nosocomial transmission is a significant source of TB infection in resource-limited settings (3), and persons with HIV infection and health care workers are at increased risk for TB infection because of their routine exposure to patients with TB in health care facilities (3-5). A lack of TB infection control in health care settings has resulted in outbreaks of TB and drug-resistant TB among patients and health care workers, leading to excess morbidity and mortality. In March 2015, in collaboration with the Nigeria Ministry of Health (MoH), CDC implemented a pilot initiative, aimed at increasing health care worker knowledge about TB infection control, assessing infection control measures in health facilities, and developing plans to address identified gaps. The approach resulted in substantial improvements in TB infection control practices at seven selected facilities, and scale-up of these measures across other facilities might lead to a reduction in TB transmission in Nigeria and globally.
authors.forename: E Kainne
authors.initials: EK
authors.lastname: Dokubo
authors.forename: Bethrand
authors.initials: B
authors.lastname: Odume
authors.forename: Virginia
authors.initials: V
authors.lastname: Lipke
authors.forename: Custodio
authors.initials: C
authors.lastname: Muianga
authors.forename: Eugene
authors.initials: E
authors.lastname: Onu
authors.forename: Ayodotun
authors.initials: A
authors.lastname: Olutola
authors.forename: Lucy
authors.initials: L
authors.lastname: Ukachukwu
authors.forename: Patricia
authors.initials: P
authors.lastname: Igweike
authors.forename: Nneka
authors.initials: N
authors.lastname: Chukwura
authors.forename: Emperor
authors.initials: E
authors.lastname: Ubochioma
authors.forename: Everistus
authors.initials: E
authors.lastname: Aniaku
authors.forename: Chinyere
authors.initials: C
authors.lastname: Ezeudu
authors.forename: Joseph
authors.initials: J
authors.lastname: Agboeze
authors.forename: Gabriel
authors.initials: G
authors.lastname: Iroh
authors.forename: Elvina
authors.initials: E
authors.lastname: Orji
authors.forename: Okezue
authors.initials: O
authors.lastname: Godwin
authors.forename: Hasiya Bello
authors.initials: HB
authors.lastname: Raji
authors.forename: S A
authors.initials: SA
authors.lastname: Aboje
authors.forename: Chijioke
authors.initials: C
authors.lastname: Osakwe
authors.forename: Henry
authors.initials: H
authors.lastname: Debem
authors.forename: Mustapha
authors.initials: M
authors.lastname: Bello
authors.forename: Dennis
authors.initials: D
authors.lastname: Onotu
authors.forename: Susan
authors.initials: S
authors.lastname: Maloney
mesh_terms: D057191:Capacity Building; D006801:Humans; D017053:Infection Control / Q000458:organization & administration*; D009549:Nigeria / Q000453:epidemiology; D015397:Program Evaluation; D014376:Tuberculosis / Q000453:epidemiology / Q000517:prevention & control*